Synthesis of peptide-oligonucleotide conjugates with single and multiple peptides attached to 2′-aldehydes through thiazolidine, oxime, and hydrazine linkages

Bioconjugate Chemistry

Volumn 13, Issue 4, 2002, Pages 822-830

  Zatsepin, Timofei S ^a   Stetsenko, Dmitry A ^b   Arzumanov, Andrey A ^b   Romanova, Elena A ^a   Gait, Michael J ^b   Oretskaya, Tatiana S ^a  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDES; AMINO ACIDS; NITROGEN COMPOUNDS; OLIGONUCLEOTIDES; RNA; SOLUTIONS;

AMINOOXY GROUPS; HYDRAZIDE GROUPS; LAMININ; N-TERMINALS; OLIGONUCLEOTIDE CONJUGATES; SMALL MOLECULES; STEM-LOOP; SYNTHESISED; TERMINAL CYSTEINE; THIAZOLIDINES;

PEPTIDES;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

ALDEHYDE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CROSS LINKING REAGENT; HYDRAZINE DERIVATIVE; OLIGONUCLEOTIDE; OLIGOPEPTIDE; OXIME; PEPTIDE NUCLEIC ACID; THIAZOLE DERIVATIVE; TRANSACTIVATOR PROTEIN;

ARTICLE; CELL FREE SYSTEM; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETICS; LONG TERMINAL REPEAT; NUCLEIC ACID HYBRIDIZATION; SYNTHESIS;

ALDEHYDES; ANTI-HIV AGENTS; CELL-FREE SYSTEM; CROSS-LINKING REAGENTS; GENE PRODUCTS, TAT; HIV LONG TERMINAL REPEAT; HYDRAZINES; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDES; OLIGOPEPTIDES; OXIMES; PEPTIDE NUCLEIC ACIDS; THIAZOLES; TRANSCRIPTION, GENETIC;

EID: 0036071516     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc020016+     Document Type: Article

References (59)

1. Synthetic oligonucleotides as therapeutics: The coming of age
2. RNA interference and small interfering RNAs
3. Triple helix formation and the antigene strategy for sequence-specific control of gene expression
4. Adaptive recognition by nucleic acid aptamers
5. Preparation and applications of peptide-oligonucleotide conjugates
6. Peptide-oligonucleotide conjugates as a new generation of antisense elements
7. Cellular delivery of impermeable effector molecules in the form of conjugates with peptides capable of mediating membrane translocation
8. Synthesis and binding properties of oligonucleotides carrying nuclear localization sequences
9. 3′ACT)-Gly-OH
10. Solid phase synthesis of directly linked peptide-oligodeoxynucleotide hybrides using standard synthesis protocols
11. Stepwise solid-phase synthesis of peptide-oligonucleotide conjugates on new solid supports
12. Solid-phase synthesis of a D-peptide-phosphorothioate oligodeoxynucleotide conjugate from two arms of a poly(ethylene glycol)-polystyrene support
13. A novel synthesis of oligonucleotide-peptide conjugates with a base-labile phosphate linker between the two components according to the allyl-protected phosphoramidite strategy
14. On-line solid-phase synthesis of oligonucleotide-peptide hybrids using silica supports
15. Studies on the synthesis of nucleotidyl-peptides. II. The preparation of a nucleotidyl-peptide having a 5′-nucleotidyl-(P- O)-serine phosphodiester bond
16. Stepwise solid-phase synthesis of peptide-oligonucleotide phosphorothioate conjugates employing Fmoc peptide chemistry
17. The synthesis of peptide-oligonucleotide conjugates by a fragment coupling approach
18. Peptide-oligonucleotide phosphorothioate conjugates with membrane translocation and nuclear localization properties
19. Synthesis and hybridization analysis of a small library of peptide-oligonucleotide conjugates
20. Convergent solution-phase synthesis of a nucleopeptide using a protected oligonucleotide
21. New DNA modification strategies involving oxime formation
22. Highly efficient synthesis of peptide-oligonucleotide conjugates: Chemoselective oxime and thiazolidine formation
23. Mitochondria transfection by oligonucleotides containing a signal peptide and vectorized by cationic liposomes
24. Unprotected peptides as building blocks for branched peptides and peptide dendrimers
25. Nucleosides and nucleotides. 126. Incorporation of a mutagenic nucleoside, 5-formyl-2′-deoxyuridine, into an oligodeoxyribonucleotide
26. Periodate oxidation in chemistry of nucleic acid. Dialdehyde derivatives of nucleosides, nucleotides, and oligonucleotides
27. Osmium tetraoxide in cis hydroxylation of unsaturated substrates
28. Synthesis of modified nucleotide building blocks containing electrophilic groups in the 2′-position
29. Chemoselective approaches to the preparation of peptide dendrimers and branched artificial proteins using unprotected peptides as building blocks
30. Efficient conjugation of peptides to oligonucleotides by "native ligation"
31. New phosphoramidite reagents for the synthesis of oligonucleotides containing a cysteine residue useful in peptide conjugation
32. Synthesis of an RNA-peptide conjugate by orthogonal ligation
33. Unprotected peptides as building blocks for the synthesis of peptide dendrimers with oxime, hydrazone, and thiazolidine linkages
34. Facile synthesis of homogeneous artificial proteins
35. Total chemical synthesis of a unique transcription factor-related protein: cMyc-Max
36. Aminooxy functionalized oligonucleotides: Preparation, on-support derivatization, and postsynthetic attachment to polymer support
37. Use of an aminooxy linker for the functionalization of oligodeoxyribonucleotides
38. Lithiated Hydrazone Anions
39. Oligonucleotide-peptide conjugates as potential antisense agents
40. Synthesis of modified oligodeoxyribonucleotides on a solid-phase support via derivatization of a selectively revealed 2′-amino-2′-deoxyuridine
41. Synthesis of 2′-modified oligodeoxynucleotides via on-column conjugation
42. Incorporation of 2′-amidonucleosides in oligodeoxynucleotides and oligoribonucleotides as a model for 2′-linked conjugates
43. 2′-Carbohydrate modifications in antisense oligonucleotide therapy: Importance of conformation, configuration and conjugation
44. Advantageous applications of azabenzotriazole (triazolopyridine)-based coupling reagents to solid-phase peptide synthesis
45. Modern machine-aided methods of oligodeoxyribonucleotide synthesis
46. Human immunodeficiency virus type-1 Tat is an integral component of the activated transcription-elongation complex
47. The human immunodeficiency virus long terminal repeat includes a specialised initiator element which is required for Tat-responsive transcription
48. System for accurate one-dimensional gel analysis including high-resolution quantitative footprinting
49. Synthesis and characteristics of modified oligodeoxyribonucleotides containing 2′-O-(2,3-dihydroxypropyl)uridine and 2′-O-(2-oxoethyl)uridine
50. Tackling Tat
51. Oligonucleotide inhibition of the interaction of HIV-1 Tat protein with the trans-activation responsive region (TAR) of HIV RNA
52. Oligonucleotide analogue interference with the HIV-1 Tat protein-TAR RNA interaction
53. Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2′-O-methyl/LNA oligoribonucleotides
54. A synthetic peptide corresponding to glycoprotein hormone alpha subunit residues 32-46 inhibits gonadotropin binding to receptor
55. A short amino acid sequence able to specify nuclear location
56. 2
57. A new access to 2′-O-alkylated ribonucleosides and properties of 2′-O-alkylated oligoribonucleotides
58. The ups and downs of nucleic acid duplex stability: Structure-stability studies on chemically modified DNA: RNA duplexes